Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded a new Study Status entry to the record history in the latest revision (v3.5.0). The older Revision: v3.4.3 was removed (2025-08-29).SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a new history entry: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision entry v3.4.2 appears in the history, and the previous revision v3.4.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedHistory shows a minor revision update from v3.4.0 to v3.4.1 with no accompanying changes to study content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page metadata now reads Revision: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page now shows 'Revision: v3.3.3' and the 'HHS Vulnerability Disclosure' link has been removed, along with the previous 'Revision: v3.3.2' entry; otherwise, the content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.